Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
about
Fibrates for primary prevention of cardiovascular disease events.Systematic review: Evaluating the effect of lipid-lowering therapy on lipoprotein and lipid values.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Carotid intima-media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutic decisions.Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
P2860
Q30241199-18C79B79-054C-4FE2-BEB9-37DC5FDDCDB1Q37182703-7F7F30E7-1C25-4530-A8AD-3D1EEB997024Q37254899-6FA15018-8AEE-421F-8382-355AC0B9D3BDQ38113494-588E40B1-CEE2-4AEA-8AAB-86A7B70B8927Q38118481-660B4B32-56E6-4140-9E4F-49663A772433Q38236677-0F0EC754-F1AE-4AE1-BE39-54A094BAA5DBQ51434591-AC77584B-F870-4812-913A-085DA73558F5
P2860
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@ast
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@en
type
label
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@ast
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@en
prefLabel
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@ast
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@en
P2093
P2860
P1476
Study design, rationale, and b ...... astatin therapy (FIRST) trial.
@en
P2093
Carolyn Setze
Christie M Ballantyne
Dawn M Carlson
James Stolzenbach
Kevin C Maki
Michael Davidson
Robert S Rosenson
Stephen J Nicholls
P2860
P304
P356
10.1007/S10557-012-6395-Z
P577
2012-08-01T00:00:00Z